Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents

dc.contributor.authorMunshi, Mumtaz A.
dc.contributor.authorNoe, Megan H.
dc.contributor.authorChiu, Yvonne E.
dc.contributor.authorStreicher, Jenna L.
dc.contributor.departmentDermatology, School of Medicine
dc.date.accessioned2023-09-01T11:07:42Z
dc.date.available2023-09-01T11:07:42Z
dc.date.issued2021
dc.description.abstractPediatric dermatologists should be aware of immunization schedules and special recommendations for patients on immunosuppressive agents due to the increased risk of vaccine-preventable infections. Prior to initiating immunosuppressive therapy, pediatric dermatologists should review a vaccine history and administer any necessary age-appropriate or catch-up vaccines. Live vaccines are typically contraindicated while on immunosuppressive therapy, while inactivated vaccines are generally safe to administer.
dc.eprint.versionAuthor's manuscript
dc.identifier.citationMunshi MA, Noe MH, Chiu YE, Streicher JL. Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents. Pediatr Dermatol. 2021;38(5):1040-1046. doi:10.1111/pde.14631
dc.identifier.urihttps://hdl.handle.net/1805/35303
dc.language.isoen_US
dc.publisherWiley
dc.relation.isversionof10.1111/pde.14631
dc.relation.journalPediatric Dermatology
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectImmunosuppression
dc.subjectImmunosuppressive agents
dc.subjectVaccination
dc.subjectVaccines
dc.titleVaccines: Considerations for pediatric dermatology patients on immunosuppressive agents
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-1734220.pdf
Size:
332.4 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: